Skip to content

MiMedx Group MDXG Return on equity

Return on equity at other companies

IAR
Integra LifeSciencesIART
-38.6%
Artivion logo
ArtivionAORT
3.1%+1.8pp
Solventum logo
SolventumSOLV
34.8%+24.1pp
Vericel logo
VericelVCEL
6.6%+5.5pp
Enovis logo
EnovisENOV
-55.5%-1,722pp
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
9.6%+1.5pp

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

Based on trailing twelve months.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's return on equity?
MiMedx Group (MDXG) reported return on equity of 13.8% in Q1 2026.
How has MiMedx Group's return on equity changed year-over-year?
MiMedx Group's return on equity decreased by 38.6% year-over-year, from 22.4% to 13.8%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.